- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0293758

Inrean Pharmaceuticals LLP
About Inrean Pharmaceuticals LLP
Data last updated:
Inrean Pharmaceuticals LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 14 December 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAN-7706. Its GSTIN is 24AAHFI3774Q1ZR (Gujarat).
The LLP has a total obligation of contribution of ₹15,000. It is led by designated partners Amol Indurkar and Nathooram Krishndatt Vyas.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 103 F.F Ratnakar Celedonia Ratnakar – 5 Balaji Restaurant Gali Nr Jodhpur Gam, Ahmedabad, Gujarat, India – 380015.
Inrean Pharmaceuticals LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0293758).
Company details
Recognitions & Rankings of Inrean Pharmaceuticals
Contact details
Inrean Pharmaceuticals LLP's registered office is in Ahmedabad, Gujarat.
- Registered Address103 F.F Ratnakar Celedonia Ratnakar – 5 Balaji Restaurant Gali Nr Jodhpur Gam, Ahmedabad, Gujarat, India – 380015
- IndustryBusiness Services, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Inrean Pharmaceuticals LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | |||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | |||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Inrean Pharmaceuticals LLP, buy the company report.
Designated partners of Inrean Pharmaceuticals LLP
Inrean Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amol Indurkar Also directs: Amnect Care Private Limited | Designated Partner | 14 Dec 2018 | 7 Years 10 Months | Current |
| Nathooram Krishndatt Vyas | Designated Partner | 14 Dec 2018 | 7 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Inrean Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inrean Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inrean Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHFI3774Q1ZR | Gujarat | Active | 19 Aug 2019 |
To see the full GST registrations and return filing status of Inrean Pharmaceuticals LLP, buy the company report.
Recent activity
Inrean Pharmaceuticals LLP has 2 designated partner changes on record since 2018: 2 appointments. The latest: Amol Indurkar was appointed as Designated Partner on 14 Dec 2018.
Frequently asked questions
Inrean Pharmaceuticals is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in other services, within the business services industry. It was incorporated on 14 December 2018 (8+ years old) and is registered under LLPIN AAN-7706.
Inrean Pharmaceuticals has 2 current designated partners:
- Amol Indurkar - Designated Partner
- Nathooram Krishndatt Vyas - Designated Partner
The latest financial statements of Inrean Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Inrean Pharmaceuticals is 24AAHFI3774Q1ZR, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Inrean Pharmaceuticals is AAN-7706. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Inrean Pharmaceuticals was incorporated on 14 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Amol Indurkar was appointed as Designated Partner on 14 Dec 2018. Nathooram Krishndatt Vyas was appointed as Designated Partner on 14 Dec 2018.
Yes, Inrean Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0293758).
The registered office of Inrean Pharmaceuticals is at 103 F.F Ratnakar Celedonia Ratnakar – 5 Balaji Restaurant Gali Nr Jodhpur Gam, Ahmedabad, Gujarat, India – 380015.
Inrean Pharmaceuticals operates in the business services industry, in the other services segment.